Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors
Sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors) are a new type of drug for the treatment of diabetes, and they have been proven to have a good hypoglycemic effect. Several lines of clinical evidence have shown that SGLT2 inhibitors can significantly reduce the risks of atherosclerosis,...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
KeAi Communications Co., Ltd.
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/7cdbba4d6c314a6a9f286fa7af3beceb |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|